Page last updated: 2024-12-05

empigen bb

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Occurs in Manufacturing Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

empigen BB: dipolar ionic detergent [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

dodecylbetaine: RN given for chloride salt; RN for parent cpd not available 7/93 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID12687
CHEMBL ID4784241
SCHEMBL ID308688
MeSH IDM0123711
PubMed CID4292413
CHEMBL ID1232088
SCHEMBL ID594518
MeSH IDM0123711

Synonyms (104)

Synonym
carboxymethyl-dodecyl-dimethylazanium
empigen bb
66455-29-6
einecs 266-368-1
SCHEMBL308688
n-(carboxymethyl)-n,n-dimethyldodecan-1-aminium
DTXSID00859530
CHEMBL4784241
PD162685
683-10-3
lauryl betaine
unii-y4p927q133
y4p927q133 ,
ammonium, (carboxymethyl)dodecyldimethyl-, hydroxide, inner salt
2-(dodecyldimethylazaniumyl)acetate
EN300-41676
c16h33no2
CHEMBL1232088
n,n-dimethyl-n-dodecylglycine
brn 3670807
lauryl-n-methylsarcosine
(carboxylatomethyl)dodecyldimethylammonium
betaine lauryldimethylaminoacetate
dodecyldimethylbetaine
(dodecyldimethylammonio)acetate
c12bet
alpha-(dodecyldimethylammonio)-omega-acetate
(dodecyldimethylammonio)ethanoate
anhitol 24b
amipol 6s
lauryldimethylbetaine
desimex i
n,n-dimethyldodecylbetaine
genagen lab
amphitol 20bs
nissan anon bl
n-(carboxymethyl)-n-lauryldimethylammonium hydroxide inner salt
rewoteric am-dml 35
rewoteric am-dml
lauryldimethylaminoacetic betaine
1-dodecanaminium, n-(carboxymethyl)-n,n-dimethyl-, hydroxide, inner salt
anon bl-sf
culveram cdg
bister ml
lauryldimethylammonioacetate
n-carboxymethyl-n,n-dimethyl-1-dodecanaminium inner salt
(carboxymethyl)dodecyldimethylammonium hydroxide inner salt
dimethyllaurylbetaine
ambiteric d 40
n-dodecyl-n,n-dimethylbetaine
lauryl dimethyl glycine
n-lauryl-n,n-dimethyl-alpha-betaine
amphitol 24b
anon bl
dodecylbetaine
lauryl-n-betaine
glycine, dodecyldimethylbetaine
n,n-dimethyl-n-laurylglycine inner salt
einecs 211-669-5
swanol am 301
rikabion a 100
dimethyllaurylaminoacetate betaine
1-dodecanaminium, n-(carboxymethyl)-n,n-dimethyl-, inner salt
empigen bb/l
laurylbetain
betadet dm 20
bs 12
nissan anon bl-sf
bs 12 (betaine surfactant)
anfoterico lb
obazoline lb
n-dodecyl-n,n-dimethylglycinate
empigen(r) bb detergent, ~35% active substance in h2o
DB07631
2-[dodecyl(dimethyl)azaniumyl]acetate
cas-66455-29-6
tox21_301433
dsstox_gsid_46978
dsstox_rid_82033
dsstox_cid_21266
NCGC00256099-01
85736-48-7
AKOS016010279
FT-0670748
2-(dodecyldimethylammonio)acetate
S12109
SCHEMBL594518
lauryl betaine [inci]
lauryl dimethylaminoacetic acid betaine
n-dodecanaminium, n-(carboxymethyl)-n,n-dimethyl-, hydroxide, inner salt
dodecylbetaine [mi]
CS-W010094
W-109593
n-dodecyl-n,n-dimethylglycine
DTXSID6041266
n,n-dimethyl-n-dodecylglycine betaine, 30% active substance in water
mfcd00084742
(lauryldimethylammonio)acetate, >=95% (hplc)
empigen(r) bb detergent, ~30% active substance
[dodecyl(dimethyl)ammonio]acetate
Q27096852
2-(dodecyldimethylammonio)acetate, 30% aqueous (w/w)
DTXSID101020488
2-(dodecyl(dimethyl)ammonio)acetate

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
"Guinea-pigs immunized with a zwitterionic detergent-extracted HSV-1 antigen preparation responded with EIA and NT serum antibody titres that were significantly greater than those elicited by a non-ionic detergent-extracted antigen preparation inoculated using a similar dosage schedule."( Protection and serum antibody responses in guinea-pigs and mice immunized with HSV-1 antigen preparations obtained using different detergents.
Ertürk, M; Jennings, R; Phillpotts, RJ; Welch, MJ, 1989
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Occurs in Manufacturing (1 Product(s))

Product Categories

Product CategoryProducts
Beauty & Personal Care1

Products

ProductBrandCategoryCompounds Matched from IngredientsDate Retrieved
AH! YES Cleanse Organic Feminine Intimate Foam Wash Fragrance Free -- 5.1 fl ozAH! YESBeauty & Personal Carecitric acid, citric acid, decyl glucoside, lauryl betaine2024-11-29 10:47:42

Protein Targets (6)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AR proteinHomo sapiens (human)Potency48.28620.000221.22318,912.5098AID1259243; AID1259247; AID743035; AID743063
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency29.96420.000214.376460.0339AID720691; AID720692
retinoid X nuclear receptor alphaHomo sapiens (human)Potency16.15090.000817.505159.3239AID1159527; AID1159531
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency38.74140.001530.607315,848.9004AID1224848; AID1224849; AID1259403
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency54.48270.000323.4451159.6830AID743065; AID743067
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency68.58960.000627.21521,122.0200AID743202; AID743219
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (27)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (44.44)18.7374
1990's8 (29.63)18.2507
2000's1 (3.70)29.6817
2010's6 (22.22)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 31.00

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index31.00 (24.57)
Research Supply Index3.09 (2.92)
Research Growth Index4.94 (4.65)
Search Engine Demand Index33.89 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (31.00)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Observational0 (0.00%)0.25%
Other21 (100.00%)84.16%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]